433 related articles for article (PubMed ID: 18584566)
1. Pharmacogenetic treatments for drug addiction: alcohol and opiates.
Haile CN; Kosten TA; Kosten TR
Am J Drug Alcohol Abuse; 2008; 34(4):355-81. PubMed ID: 18584566
[TBL] [Abstract][Full Text] [Related]
2. Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.
Gelernter J; Gueorguieva R; Kranzler HR; Zhang H; Cramer J; Rosenheck R; Krystal JH;
Alcohol Clin Exp Res; 2007 Apr; 31(4):555-63. PubMed ID: 17374034
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy of addictions.
Kreek MJ; LaForge KS; Butelman E
Nat Rev Drug Discov; 2002 Sep; 1(9):710-26. PubMed ID: 12209151
[TBL] [Abstract][Full Text] [Related]
4. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.
Ray LA; Hutchison KE
Arch Gen Psychiatry; 2007 Sep; 64(9):1069-77. PubMed ID: 17768272
[TBL] [Abstract][Full Text] [Related]
5. The μ-opioid receptor and treatment response to naltrexone.
Thorsell A
Alcohol Alcohol; 2013; 48(4):402-8. PubMed ID: 23543091
[TBL] [Abstract][Full Text] [Related]
6. Potential of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disorders.
McCann DJ
Clin Pharmacol Ther; 2008 Apr; 83(4):627-30. PubMed ID: 18212797
[TBL] [Abstract][Full Text] [Related]
7. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacological treatment of substance dependence from a neuroscientific perspective (I): opiates and cocaine].
Haro G; Cervera G; Martínez-Raga J; Pérez-Gálvez B; Fernández-Garcés M; Sanjuan J
Actas Esp Psiquiatr; 2003; 31(4):205-19. PubMed ID: 12838444
[TBL] [Abstract][Full Text] [Related]
9. Clinical treatment of opioid addiction and dependence.
Ling W; Rawson RA; Compton M
Methods Mol Med; 2003; 84():285-95. PubMed ID: 12703332
[No Abstract] [Full Text] [Related]
10. The Asp40 mu-opioid receptor allele does not predict naltrexone treatment efficacy in heavy drinkers.
Mitchell JM; Fields HL; White RL; Meadoff TM; Joslyn G; Rowbotham MC
J Clin Psychopharmacol; 2007 Feb; 27(1):112-5. PubMed ID: 17224736
[No Abstract] [Full Text] [Related]
11. Managing opioid addiction with buprenorphine.
Donaher PA; Welsh C
Am Fam Physician; 2006 May; 73(9):1573-8. PubMed ID: 16719249
[TBL] [Abstract][Full Text] [Related]
12. Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone.
Oslin DW; Berrettini WH; O'Brien CP
Addict Biol; 2006 Sep; 11(3-4):397-403. PubMed ID: 16961767
[TBL] [Abstract][Full Text] [Related]
13. Buprenorphine for opioid dependence.
Milne M; Crouch BI; Caravati EM
J Pain Palliat Care Pharmacother; 2009; 23(2):153-5. PubMed ID: 19492216
[TBL] [Abstract][Full Text] [Related]
14. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
Digiusto E; Shakeshaft A; Ritter A; O'Brien S; Mattick RP;
Addiction; 2004 Apr; 99(4):450-60. PubMed ID: 15049745
[TBL] [Abstract][Full Text] [Related]
15. A brief review of the genetics and pharmacogenetics of opioid use disorders.
Berrettini W
Dialogues Clin Neurosci; 2017 Sep; 19(3):229-236. PubMed ID: 29302220
[TBL] [Abstract][Full Text] [Related]
16. Opioid dependence: rationale for and efficacy of existing and new treatments.
Fiellin DA; Friedland GH; Gourevitch MN
Clin Infect Dis; 2006 Dec; 43 Suppl 4():S173-7. PubMed ID: 17109303
[TBL] [Abstract][Full Text] [Related]
17. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacological effects of a mu-opioid receptor antagonist naltrexone on alcohol dependence].
Kato H
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Oct; 43(5):697-704. PubMed ID: 19068776
[TBL] [Abstract][Full Text] [Related]
19. Naltrexone in alcohol dependence.
Hartmann PM
Am Fam Physician; 1997 Apr; 55(5):1877-9, 1883-4. PubMed ID: 9105212
[TBL] [Abstract][Full Text] [Related]
20. Opiate addiction in China: current situation and treatments.
Tang YL; Zhao D; Zhao C; Cubells JF
Addiction; 2006 May; 101(5):657-65. PubMed ID: 16669899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
